Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Kaleo has launched the AUVI-Q Speaks Up campaign to share the stories of patients, caregivers…
Enthusiasm for Akeso’s first-line non-small cell lung cancer data on ivonescimab, in partnership with Summit…
Johnson & Johnson plans to lay off 56 employees at its New Brunswick headquarters in…
Outlook moves towards possibility of U.S. consenting to eye drops that were downplayed three times after FDA appeal wins
By healthadmin
Outlook Therapeutics has won the difficult battle to commercialize the ophthalmic version of Roche’s Avastin…
Explore the key challenges in drug discovery for 2026, including AI integration, regulatory hurdles, and precision medicine trends affecting biopharma pipelines.
Amid policy and pricing headwinds, U.S. health care and life sciences face ‘vast areas of opportunity’: study
By healthadmin
Healthcare and life sciences companies face tremendous pressure to remain profitable amid turbulent regulatory, pricing…
Biogen investigated by Italian regulators over multiple sclerosis ‘market abuse’ claims
By healthadmin
Italy’s antitrust agency, the Italian Competition Authority (AGCM), is investigating Biogen and its Italian subsidiary…
Radiopharmaceutical company Lanteus considers potential $7 billion acquisition by Curium: Bloomberg
By healthadmin
A multibillion-dollar acquisition in the radiopharmaceutical space could be on the horizon, as Lantheus Holding…
Gilead’s Hepcrudex Hepatitis D Treatment Wins U.S. Approval After Previous FDA Manufacturing Rejection
By healthadmin
More than three years after Gilead Sciences’ hepatitis D drug brevirtide was rejected by the…
Real-world evidence in the age of AI: What you uncover is determined by what you build
By healthadmin
Author: Guy Amster, Senior Principal Machine Learning Engineer, Flatiron HealthReal-world evidence (RWE) has long held…